Molecular Endocrinology, Vol 9, 1814-1824, Copyright © 1995 by Endocrine Society

ARTICLES

Vitamin D3-retinoid X receptor dimerization, DNA binding, and transactivation are differentially affected by analogs of 1,25- dihydroxyvitamin D3

B Cheskis, BD Lemon, M Uskokovic, PT Lomedico and LP Freedman
Cell Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center New York, New York 10021, USA.

A number of analogs of 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] have been synthesized that act as more potent inducers of cellular differentiation and inhibitors of cell growth than the natural ligand; at the same time, many of the analogs have reduced hypercalcemic properties. This combination makes these compounds attractive candidates for clinical use. The mechanism by which the analogs act, however, is unclear. Potentially, the analogs could be taken up more readily, be more slowly catabolized, or have higher binding affinities for the vitamin D receptor (VDR). Analogs of 1,25-(OH)2D3 could also differentially modulate one or more of the activities of VDR, namely dimerization, DNA binding, and/or transcriptional regulation. To directly examine this latter possibility, we used a sensitive assay for the kinetics of dimerization and DNA binding, surface plasmon resonance, and report here that three 1,25-(OH)2D3 analogs, 1,25-(OH)2- 16-ene-23-yne-D3, 1,25-(OH)2-16-ene-23-yne-26,27-di home-D3, and 1,25- (OH)2-26,27-hexafluoro-16-ene-23-yne-D3, all confer distinct rate and equilibrium constants for VDR-retinoid X receptor heterodimerization and DNA binding to a specific vitamin D response element relative to the natural ligand. In response to the hexafluoro analog, the apparent Kd for DNA binding by VDR was significantly lower than that for 1,25- (OH)2D3, and correspondingly, in vivo transactivation from a responsive reporter was greater. Interestingly, solution heterodimerization was not affected by this analog. These results suggest that vitamin D analogs do indeed confer biological effects by acting directly and differentially at the level of VDR, and that specific vitamin D analogs can act on distinct receptor functions.

This article has been cited by other articles:

				Y. Chen, A. Kerimo, S. Khan, and L.-N. Wei Real-Time Analysis of Molecular Interaction of Retinoid Receptors and Receptor-Interacting Protein 140 (RIP140) Mol. Endocrinol., November 1, 2002; 16(11): 2528 - 2537. [Abstract] [Full Text] [PDF]

				G.-J. C. M. van den Bemd, M. Jhamai, A. Staal, A. J. van Wijnen, J. B. Lian, G. S. Stein, H. A. P. Pols, and J. P. T. M. van Leeuwen A Central Dinucleotide within Vitamin D Response Elements Modulates DNA Binding and Transactivation by the Vitamin D Receptor in Cellular Response to Natural and Synthetic Ligands J. Biol. Chem., April 19, 2002; 277(17): 14539 - 14546. [Abstract] [Full Text] [PDF]

				Y.-Y. Liu, C. Nguyen, and S. Peleg Regulation of Ligand-Induced Heterodimerization and Coactivator Interaction by the Activation Function-2 Domain of the Vitamin D Receptor Mol. Endocrinol., November 1, 2000; 14(11): 1776 - 1787. [Abstract] [Full Text]

				W. Yang and L. P. Freedman 20-Epi Analogues of 1,25-Dihydroxyvitamin D3 Are Highly Potent Inducers of DRIP Coactivator Complex Binding to the Vitamin D3 Receptor J. Biol. Chem., June 11, 1999; 274(24): 16838 - 16845. [Abstract] [Full Text] [PDF]

				S. A. Rivkees, M. Chen, J. Kulkarni, J. Browne, and Z. Zhao Characterization of the Murine A1 Adenosine Receptor Promoter, Potent Regulation by GATA-4 and Nkx2.5 J. Biol. Chem., May 14, 1999; 274(20): 14204 - 14209. [Abstract] [Full Text] [PDF]

				L. P. Freedman Transcriptional Targets of the Vitamin D3 Receptor–Mediating Cell Cycle Arrest and Differentiation J. Nutr., February 1, 1999; 129(2): 581 - 581. [Abstract] [Full Text] [PDF]

				G. JONES, S. A. STRUGNELL, and H. F. DeLUCA Current Understanding of the Molecular Actions of Vitamin D Physiol Rev, October 1, 1998; 78(4): 1193 - 1231. [Abstract] [Full Text] [PDF]

				C. Rachez, Z. Suldan, J. Ward, C.-P. B. Chang, D. Burakov, H. Erdjument-Bromage, P. Tempst, and L. P. Freedman A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system Genes & Dev., June 15, 1998; 12(12): 1787 - 1800. [Abstract] [Full Text]

				A. Takeuchi, G. S. Reddy, T. Kobayashi, T. Okano, J. Park, and S. Sharma Nuclear Factor of Activated T Cells (NFAT) as a Molecular Target for 1{alpha},25-Dihydroxyvitamin D3-Mediated Effects J. Immunol., January 1, 1998; 160(1): 209 - 218. [Abstract] [Full Text] [PDF]

				T. N. Collingwood, A. Butler, Y. Tone, R. J. Clifton-Bligh, M. G. Parker, and V. K. K. Chatterjee Thyroid Hormone-mediated Enhancement of Heterodimer Formation between Thyroid Hormone Receptor beta  and Retinoid X Receptor J. Biol. Chem., May 16, 1997; 272(20): 13060 - 13065. [Abstract] [Full Text] [PDF]

				B. J. Cheskis, S. Karathanasis, and C. R. Lyttle Estrogen Receptor Ligands Modulate Its Interaction with DNA J. Biol. Chem., April 25, 1997; 272(17): 11384 - 11391. [Abstract] [Full Text] [PDF]

				X.-Y. Zhao, T. R. Eccleshall, A. V. Krishnan, C. Gross, and D. Feldman Analysis of Vitamin D Analog-Induced Heterodimerization of Vitamin D Receptor with Retinoid X Receptor Using the Yeast Two-Hybrid System Mol. Endocrinol., March 1, 1997; 11(3): 366 - 378. [Abstract] [Full Text]

				C. Zhang, T. A. Baudino, D. R. Dowd, H. Tokumaru, W. Wang, and P. N. MacDonald Ternary Complexes and Cooperative Interplay between NCoA-62/Ski-interacting Protein and Steroid Receptor Coactivators in Vitamin D Receptor-mediated Transcription J. Biol. Chem., October 26, 2001; 276(44): 40614 - 40620. [Abstract] [Full Text] [PDF]